Message From The Director
The primary goal of BMEII is to develop unique approaches to biomedical sciences and therapeutic interventions by bridging basic and translational research and education by leveraging expertise in medicine and engineering. Engineering and engineering science are fundamentals to understanding the basic biomedical phenomena and associated therapeutic interventions. Major inventions and innovations that have shaped modern medicine were born out of close collaborations of engineers with biomedical researchers and clinicians, ranging from medical devices and highly sensitive and accurate bioimaging systems, to new drug target discovery and accelerated drug discovery. We have and we will continue to wisely and strategically invest in BMEII in order to lead in biomedical discovery, disease understanding and translation to patient care. By exploring our website you will learn how BMEII is unique due to its dual focus on research and education, the interrelationships between biomedical research and engineering, and spanning the molecular to human dimensions of biomedical research. I look forward to a future of advancing biomedical scientific discoveries thanks to the wonderful faculty, trainees, staff and collaborators at BMEII.
Subtle changes in an individual’s heartbeat, which can be measured on an Apple Watch, are able to signal the onset of COVID-19 up to seven days before individuals are diagnosed with the infection. That preliminary observation was made by researchers at the Icahn...
Mount Sinai Hospital opens one of the first centers to study and treat people with what being called “Post-acute COVID Syndrome.”
Please click on the image to watch the 60 Minutes segment. New York, NY (November 22, 2020) — COVID-19 was initially thought to be a disease that was serious for the eldery and people with preexisting conditions. A potentially tough, but temporary respiratory illness...
Nanobiologic immunotherapy uses tiny, bioengineered material to harness immune systemNew York, NY (October 29, 2020) — A groundbreaking new type of cancer immunotherapy developed at the Icahn School of Medicine at Mount Sinai trains the innate immune system to help it...
Artificial intelligence–enabled rapid diagnosis of patients with COVID-19
Xueyan Mei, Hao-Chih Lee, […] Yang Yang
Nat Med (2020).
Probing myeloid cell dynamics in ischaemic heart disease by nanotracer hot-spot imaging
Max L. Senders, Anu E. Meerwaldt, ... Willem J. M. Mulder
Nat. Nanotechnol. 15, 398–405 (2020).